Encoded Therapeutics

David McNinch, Chief Business Officer 

Oct. 11 | 9:45am | Oxford Biomedica Ballroom 

San Francisco, CA 


In-person Presentation 

Encoded is a biotech company that engineers gene therapies to tackle challenging targets and diseases. Our research platform, driven on machine learning, targets cell specificity for greater selectivity and potency across many tissue types. We endeavor to create gene therapies with optimal on and off target expression. Encoded has its own burgeoning pipeline focusing on pediatric CNS disorders and is open to partnering in new cell and tissue types. 



By using this website you agree to accept our Privacy Policy and Terms & Conditions